Logo image of BLCO

BAUSCH + LOMB CORP (BLCO) Stock Fundamental Analysis

NYSE:BLCO - New York Stock Exchange, Inc. - CA0717051076 - Common Stock - Currency: USD

14.44  +0.12 (+0.84%)

After market: 14.44 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BLCO. BLCO was compared to 187 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of BLCO while its profitability can be described as average. While showing a medium growth rate, BLCO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

BLCO had positive earnings in the past year.
In the past year BLCO had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BLCO reported negative net income in multiple years.
Of the past 5 years BLCO 4 years had a positive operating cash flow.
BLCO Yearly Net Income VS EBIT VS OCF VS FCFBLCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

With a decent Return On Assets value of -2.70%, BLCO is doing good in the industry, outperforming 68.98% of the companies in the same industry.
BLCO has a better Return On Equity (-5.69%) than 70.59% of its industry peers.
The Return On Invested Capital of BLCO (0.86%) is better than 66.84% of its industry peers.
BLCO had an Average Return On Invested Capital over the past 3 years of 1.59%. This is significantly below the industry average of 7.89%.
Industry RankSector Rank
ROA -2.7%
ROE -5.69%
ROIC 0.86%
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.59%
ROIC(5y)1.92%
BLCO Yearly ROA, ROE, ROICBLCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4

1.3 Margins

BLCO has a Operating Margin of 2.63%. This is in the better half of the industry: BLCO outperforms 66.84% of its industry peers.
In the last couple of years the Operating Margin of BLCO has declined.
With a Gross Margin value of 60.03%, BLCO perfoms like the industry average, outperforming 59.36% of the companies in the same industry.
BLCO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.63%
PM (TTM) N/A
GM 60.03%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
BLCO Yearly Profit, Operating, Gross MarginsBLCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BLCO is destroying value.
The number of shares outstanding for BLCO has been increased compared to 1 year ago.
Compared to 5 years ago, BLCO has more shares outstanding
The debt/assets ratio for BLCO is higher compared to a year ago.
BLCO Yearly Shares OutstandingBLCO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
BLCO Yearly Total Debt VS Total AssetsBLCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

BLCO has an Altman-Z score of 0.83. This is a bad value and indicates that BLCO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BLCO (0.83) is comparable to the rest of the industry.
BLCO has a Debt/Equity ratio of 0.75. This is a neutral value indicating BLCO is somewhat dependend on debt financing.
BLCO has a worse Debt to Equity ratio (0.75) than 73.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF N/A
Altman-Z 0.83
ROIC/WACC0.11
WACC7.5%
BLCO Yearly LT Debt VS Equity VS FCFBLCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

BLCO has a Current Ratio of 1.56. This is a normal value and indicates that BLCO is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.56, BLCO is doing worse than 74.33% of the companies in the same industry.
BLCO has a Quick Ratio of 1.56. This is a bad value and indicates that BLCO is not financially healthy enough and could expect problems in meeting its short term obligations.
BLCO has a worse Quick ratio (0.96) than 78.61% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 0.96
BLCO Yearly Current Assets VS Current LiabilitesBLCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for BLCO have decreased strongly by -32.39% in the last year.
BLCO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.94%.
The Revenue has been growing slightly by 4.87% on average over the past years.
EPS 1Y (TTM)-32.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)11.94%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%3.46%

3.2 Future

Based on estimates for the next years, BLCO will show a very strong growth in Earnings Per Share. The EPS will grow by 24.11% on average per year.
Based on estimates for the next years, BLCO will show a small growth in Revenue. The Revenue will grow by 4.45% on average per year.
EPS Next Y-20.51%
EPS Next 2Y12.29%
EPS Next 3Y19.54%
EPS Next 5Y24.11%
Revenue Next Year5.41%
Revenue Next 2Y5.44%
Revenue Next 3Y5.22%
Revenue Next 5Y4.45%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BLCO Yearly Revenue VS EstimatesBLCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
BLCO Yearly EPS VS EstimatesBLCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5 2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

BLCO is valuated quite expensively with a Price/Earnings ratio of 30.08.
75.40% of the companies in the same industry are more expensive than BLCO, based on the Price/Earnings ratio.
BLCO's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.93.
BLCO is valuated rather expensively with a Price/Forward Earnings ratio of 18.47.
Based on the Price/Forward Earnings ratio, BLCO is valued cheaply inside the industry as 80.21% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 37.78. BLCO is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 30.08
Fwd PE 18.47
BLCO Price Earnings VS Forward Price EarningsBLCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

BLCO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BLCO is cheaper than 78.07% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.42
BLCO Per share dataBLCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

BLCO's earnings are expected to grow with 19.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.29%
EPS Next 3Y19.54%

More info and screens

0

5. Dividend

5.1 Amount

BLCO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BAUSCH + LOMB CORP

NYSE:BLCO (7/28/2025, 8:10:42 PM)

After market: 14.44 0 (0%)

14.44

+0.12 (+0.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners10.83%
Inst Owner Change-0.37%
Ins Owners0.45%
Ins Owner Change20.17%
Market Cap5.11B
Analysts72.63
Price Target15.13 (4.78%)
Short Float %9.86%
Short Ratio5.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-178.13%
Min EPS beat(2)-360.35%
Max EPS beat(2)4.09%
EPS beat(4)3
Avg EPS beat(4)-86.35%
Min EPS beat(4)-360.35%
Max EPS beat(4)6.68%
EPS beat(8)6
Avg EPS beat(8)-34.35%
EPS beat(12)9
Avg EPS beat(12)-16.97%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.61%
Min Revenue beat(2)-3.07%
Max Revenue beat(2)-0.16%
Revenue beat(4)1
Avg Revenue beat(4)-0.35%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)1.93%
Revenue beat(8)4
Avg Revenue beat(8)1.13%
Revenue beat(12)7
Avg Revenue beat(12)0.92%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.28%
PT rev (3m)-19.46%
EPS NQ rev (1m)-14.39%
EPS NQ rev (3m)-56.22%
EPS NY rev (1m)-2.82%
EPS NY rev (3m)-26.04%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)-0.54%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.65%
Valuation
Industry RankSector Rank
PE 30.08
Fwd PE 18.47
P/S 1.06
P/FCF N/A
P/OCF 30.78
P/B 0.8
P/tB N/A
EV/EBITDA 17.42
EPS(TTM)0.48
EY3.32%
EPS(NY)0.78
Fwd EY5.41%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)0.47
OCFY3.25%
SpS13.65
BVpS17.98
TBVpS-4.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.7%
ROE -5.69%
ROCE 1.09%
ROIC 0.86%
ROICexc 0.87%
ROICexgc 2.86%
OM 2.63%
PM (TTM) N/A
GM 60.03%
FCFM N/A
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.59%
ROIC(5y)1.92%
ROICexc(3y)1.64%
ROICexc(5y)1.97%
ROICexgc(3y)5.47%
ROICexgc(5y)6.76%
ROCE(3y)2.02%
ROCE(5y)2.43%
ROICexcg growth 3Y-21.86%
ROICexcg growth 5Y-17.06%
ROICexc growth 3Y-20.45%
ROICexc growth 5Y-15.79%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
F-Score3
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF N/A
Debt/EBITDA 8.57
Cap/Depr 77.31%
Cap/Sales 6.92%
Interest Coverage 250
Cash Conversion 29.7%
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 0.96
Altman-Z 0.83
F-Score3
WACC7.5%
ROIC/WACC0.11
Cap/Depr(3y)53.43%
Cap/Depr(5y)52.81%
Cap/Sales(3y)5.03%
Cap/Sales(5y)5.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y-20.51%
EPS Next 2Y12.29%
EPS Next 3Y19.54%
EPS Next 5Y24.11%
Revenue 1Y (TTM)11.94%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%3.46%
Revenue Next Year5.41%
Revenue Next 2Y5.44%
Revenue Next 3Y5.22%
Revenue Next 5Y4.45%
EBIT growth 1Y-42.79%
EBIT growth 3Y-15.55%
EBIT growth 5Y-13.93%
EBIT Next Year40.8%
EBIT Next 3Y21.5%
EBIT Next 5Y15.15%
FCF growth 1Y-244.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-41.96%
OCF growth 3Y-35.71%
OCF growth 5Y-21.91%